A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects
Public ClinicalTrials.gov record NCT04480710. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
AMBITION: A Phase 2A, Multiple-Center, Single-Blind, Placebo-Controlled Study To Evaluate The Safety and Tolerability of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, single-blind, placebo-controlled, once daily (QD) dose study of CRV431 in presumed NASH F2/F3 subjects.
Study identification
- NCT ID
- NCT04480710
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 47 participants
Conditions and interventions
Conditions
Interventions
- CRV431 75mg Drug
- Placebo (1 softgel) Drug
- CRV431 225mg Drug
- Placebo (3 softgels) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 23, 2020 (Actual)
- Primary completion
- Jun 29, 2021 (Actual)
- Completion
- Oct 30, 2021 (Actual)
- Last update posted
- Jul 15, 2022
2020 – 2021
United States locations
- U.S. sites
- 9
- U.S. states
- 5
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Conquest Clinical Research | Orange | California | 92866 | — |
| Alliance Clinical Research | Poway | California | 92064 | — |
| La Salud Research, Inc. | Miami | Florida | 33155 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Covenant Research, LLC. | Sarasota | Florida | 34249 | — |
| Gastrointestinal Specialists of Georgia | Marietta | Georgia | 30060 | — |
| Aventiv Research Inc. | Columbus | Ohio | 43213 | — |
| Quality Research Inc. | San Antonio | Texas | 78209 | — |
| Pinnacle Research Group | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04480710, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 15, 2022 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04480710 live on ClinicalTrials.gov.